La Jolla Pharmaceutical Company

La Jolla Pharmaceutical Companyverified

LJPC

Price:

$6.19

Market Cap:

$0

La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. The company offers GIAPREZA, a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock; and XERAVA, a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age and older. It offers GIAPREZA and XERAVA to hospitals and other healthcare organizations in the United States. Its product candidates that are in early stage clinical or preclinical development include TP-6076, an IV formulation of a fully synthetic ...[Read more]

Industry

Biotechnology

IPO Date

1994-06-03

Stock Exchange

NASDAQ

Ticker

LJPC

The Current Ratio as of December 2025 (TTM) for La Jolla Pharmaceutical Company (LJPC) is 3.82

According to La Jolla Pharmaceutical Company’s latest financial reports and current stock price. The company's current Current Ratio is 3.82. This represents a change of -3.87% compared to the average of 3.97 of the last 4 quarters.

La Jolla Pharmaceutical Company (LJPC) Historical Current Ratio (quarterly & annually)

How has LJPC Current Ratio performed in the past?

The mean historical Current Ratio of La Jolla Pharmaceutical Company over the last ten years is 10.31. The current 3.82 Current Ratio has changed 3.60% with respect to the historical average. Over the past ten years (40 quarters), LJPC's Current Ratio was at its highest in in the September 2014 quarter at 33.64. The Current Ratio was at its lowest in in the September 2012 quarter at 0.26.

Quarterly (TTM)
Annual

Average

10.31

Median

6.43

Minimum

2.95

Maximum

26.46

La Jolla Pharmaceutical Company (LJPC) Current Ratio by Quarter and Year

Discovering the peaks and valleys of La Jolla Pharmaceutical Company Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 4.73%

Maximum Annual Current Ratio = 26.46

Minimum Annual Increase = -73.89%

Minimum Annual Current Ratio = 2.95

Quarterly (TTM)
Annual
YearCurrent RatioChange
20213.8229.19%
20202.95-25.46%
20193.96-33.38%
20185.9517.36%
20175.07-26.63%
20166.91-73.89%
201526.469.52%
201424.16203.52%
20137.96-49.87%
201215.884.73%

La Jolla Pharmaceutical Company (LJPC) Average Current Ratio

How has LJPC Current Ratio performed in the past?

The current Current Ratio of La Jolla Pharmaceutical Company (LJPC) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.58

5-year avg

4.35

10-year avg

10.31

La Jolla Pharmaceutical Company (LJPC) Current Ratio vs. Peers

How is LJPC’s Current Ratio compared to its peers?

La Jolla Pharmaceutical Company’s Current Ratio is less than F-star Therapeutics, Inc. (6.98), less than eXoZymes, Inc. (4.53), greater than Paratek Pharmaceuticals, Inc. (3.66), less than Pardes Biosciences, Inc. (9.81), less than Selecta Biosciences, Inc. (13.33), less than aTyr Pharma, Inc. (5.93), less than NGM Biopharmaceuticals, Inc. (7.79), less than Theseus Pharmaceuticals, Inc. (17.79), greater than Sesen Bio, Inc. (0.48), less than LENZ Therapeutics, Inc. (20.54),

Build a custom stock screener for La Jolla Pharmaceutical Company (LJPC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like La Jolla Pharmaceutical Company using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

La Jolla Pharmaceutical Company (LJPC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like La Jolla Pharmaceutical Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is La Jolla Pharmaceutical Company's Current Ratio?

How is the Current Ratio calculated for La Jolla Pharmaceutical Company (LJPC)?

What is the highest Current Ratio for La Jolla Pharmaceutical Company (LJPC)?

What is the 3-year average Current Ratio for La Jolla Pharmaceutical Company (LJPC)?

What is the 5-year average Current Ratio for La Jolla Pharmaceutical Company (LJPC)?

How does the current Current Ratio for La Jolla Pharmaceutical Company (LJPC) compare to its historical average?